An Interactive Preventive Health Record to Increase Colorectal Cancer Screening (MyCRCS)
Colorectal Cancer Screening
About this trial
This is an interventional prevention trial for Colorectal Cancer Screening focused on measuring Colorectal Cancer Screening, Ambulatory Care, Patient-Centered Care, Intervention Studies, Longitudinal Studies
Eligibility Criteria
Inclusion Criteria:
- Adults 50-75 years
- Non-adherent to CRCS guidelines (i.e., no FOBT in last year, no sigmoidoscopy or barium enema in last 5 years, and no colonoscopy in last 10 years)
- English-speaking
- Have computer access (e.g. home, work, library)
- Additional eligibility for Phase I: focus group participants will be ineligible for the subsequent prototype testing and cognitive/usability testing interviews
- Additional eligibility for Phase I: prototype testing participants will be ineligible for the cognitive/usability testing interviews
- Additional eligibility for Phase II: Seen in the clinic in the last 2 years
Exclusion Criteria:
- Personal CRC history
- Additional exclusion for Phase III: Patients seen at any clinic participating in Phase II
Sites / Locations
- Temple University - General Internal Medicine
- Virginia Ambulatory Care Outcomes Research Network
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
No Intervention
Phase II: MyCRCS+Prefs
Phase II: MyCRCS+Prefs+Barriers
Phase II: Usual Care
Patients who are identified by the IPHR as study participants will see an attractive link. In the Prefs arm, via question prompt lists, patients will first identify their CRCS preference using previously developed elicitation strategies. Tailoring will be used to increase salience of information, motivation, communication, and action plans. We envision the Prefs+ arm in its entirety will be 5-7 minutes, but will depend on Phase I formative work. If the patient remains non-adherent, they will receive an e-mail reminder generated by the IPHR (specific text and frequency determined in Phase I). The Prefs content is identical to the preference portion of the Prefs+Barriers arm, which will allow us to assess the incremental benefit of addressing preferences only and the incremental benefit of addressing preferences and barriers.
Patients who are identified by the IPHR as study participants will see an attractive link. In the Prefs+Barriers arm, via question prompt lists, patients will first identify their CRCS preference using previously developed elicitation strategies, and subsequently based on their test preference determine their top 3 test-specific barriers/concerns in "real time". Tailoring will be used to increase salience of information, motivation, communication, and action plans. We envision the Prefs+Barriers arm in its entirety will be 15-25 minutes, but will depend on Phase I formative work. If the patient remains non-adherent, they will receive an e-mail reminder generated by the IPHR (specific text and frequency determined in Phase I). The Prefs content is identical to the preference portion of the Prefs+Barriers arm, which will allow us to assess the incremental benefit of addressing preferences only and the incremental benefit of addressing preferences and barriers
The IPHR will be programmed so that where the IPHR-CRCS would normally present patients, who based on their demographics and health conditions, with content advising them to seek CRCS and links to third-party sites, they would instead be randomized to receive the usual care (IPHR-CRCS).